GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...

In prominent research fields such as immunotherapy, vaccine development, drug discovery, and proteomics, target screening is frequently carried out using peptide libraries, which are systematic ...

GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...

R&D Innovation to Lead the Future, Deepening Customer Value Creation From the performance during the 2023 reporting period, GenScript Group's overall development is optimistic, with each business ...

Neoantigen vaccines are a type of personalized cancer vaccine. While clinical trials have shown promising results, it is important to note that neoantigen vaccines are still in the early stages of ...

GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...

In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...